Compare
BioCorRx Inc. vs Concentra Group Holdings Parent, Inc. vs Acadia Healthcare Company, Inc.
| Latest fiscal year | BioCorRx Inc. BICX | Concentra Group Holdings Parent, Inc. CON | Acadia Healthcare Company, Inc. ACHC |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $797.2K | $2.16B | $3.31B |
| Revenue growth (YoY) | n/m | +13.9% | +5.0% |
| Gross margin | n/a | n/a | n/a |
| Operating margin | -606.0% | 15.4% | n/a |
| Net margin | -431.5% | 7.7% | -33.3% |
| Net income | -$3.44M | $166.41M | -$1.10B |
| EPS (Diluted) | -$0.19 | $1.30 | -$12.16 |
| Operating cash flow | -$2.30M | $279.40M | $131.90M |
| Free cash flow | n/a | $197.06M | -$439.91M |
| Cash & equivalents | n/a | $79.90M | $133.24M |
| Total assets | $2.15M | $2.86B | $5.53B |
| Total liabilities | $13.67M | $2.44B | $3.39B |
| Shareholders' equity | -$11.22M | $401.02M | $1.95B |
| Return on year-end equity | n/a | 41.5% | -56.6% |
| Shares outstanding | 24.49M | 128.63M | 90.45M |
Revenue, most recent five fiscal years
| Fiscal year | BioCorRx Inc. | Concentra Group Holdings Parent, Inc. | Acadia Healthcare Company, Inc. |
|---|---|---|---|
| Latest | $797.2K Ended 2025-12-31 | $2.16B Ended 2025-12-31 | $3.31B Ended 2025-12-31 |
| 1 year earlier | $7.7K Ended 2024-12-31 | $1.90B Ended 2024-12-31 | $3.15B Ended 2024-12-31 |
| 2 years earlier | $89.2K Ended 2023-12-31 | $1.84B Ended 2023-12-31 | $2.93B Ended 2023-12-31 |
| 3 years earlier | $213.8K Ended 2022-12-31 | $1.72B Ended 2022-12-31 | $2.61B Ended 2022-12-31 |
| 4 years earlier | $48.3K Ended 2021-12-31 | n/a | $2.31B Ended 2021-12-31 |